Related references
Note: Only part of the references are listed.Hyperuricemia causes kidney damage by promoting autophagy and NLRP3-mediated inflammation in rats with urate oxidase deficiency
Mian Wu et al.
DISEASE MODELS & MECHANISMS (2021)
NLRP3 inflammasome in cancer and metabolic diseases
Bhesh Raj Sharma et al.
NATURE IMMUNOLOGY (2021)
NLRP3 inflammasome negatively regulates podocyte autophagy in diabetic nephropathy
Yun Hou et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2020)
Phloretin ameliorates hyperuricemia-induced chronic renal dysfunction through inhibiting NLRP3 inflammasome and uric acid reabsorption
Danli Cui et al.
PHYTOMEDICINE (2020)
Inflammasome activation in podocytes: a new mechanism of glomerular diseases
Wei Xiong et al.
INFLAMMATION RESEARCH (2020)
Punicalagin Protects Diabetic Nephropathy by Inhibiting Pyroptosis Based on TXNIP/NLRP3 Pathway
Xin An et al.
NUTRIENTS (2020)
The role of uric acid in inflammasome-mediated kidney injury
Tarcio Teodoro Braga et al.
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION (2020)
Circadian rhythms and the gut microbiota: from the metabolic syndrome to cancer
Faraz Bishehsari et al.
NATURE REVIEWS ENDOCRINOLOGY (2020)
Scutellarin Ameliorates Renal Injury via Increasing CCN1 Expression and Suppressing NLRP3 Inflammasome Activation in Hyperuricemic Mice
Guozheng Li et al.
FRONTIERS IN PHARMACOLOGY (2020)
Endoplasmic reticulum stress related factor IRE1α regulates TXNIP/NLRP3-mediated pyroptosis in diabetic nephropathy
Ruiqiong Ke et al.
EXPERIMENTAL CELL RESEARCH (2020)
The role of lysosomal cysteine cathepsins in NLRP3 inflammasome activation
Rhiannon Campden et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2019)
NLRP3 inflammasome and lipid metabolism analysis based on UPLC-Q-TOF-MS in gouty nephropathy
Yan-Zi Zhang et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2019)
Rac1 GTPase Inhibition Blocked Podocyte Injury and Glomerular Sclerosis during Hyperhomocysteinemia via Suppression of Nucleotide-Binding Oligomerization Domain-Like Receptor Containing Pyrin Domain 3 Inflammasome Activation
Qinghua Zhang et al.
KIDNEY & BLOOD PRESSURE RESEARCH (2019)
The role of inflammasomes in kidney disease
Takanori Komada et al.
NATURE REVIEWS NEPHROLOGY (2019)
Interleukin-1β Inhibition for Chronic Kidney Disease in Obese Mice With Type 2 Diabetes
Yutian Lei et al.
FRONTIERS IN IMMUNOLOGY (2019)
A small molecule inhibitor MCC950 ameliorates kidney injury in diabetic nephropathy by inhibiting NLRP3 inflammasome activation
CongXiao Zhang et al.
DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY (2019)
Pathogenic role of innate immunity in a model of chronic NO inhibition associated with salt overload
Fernanda Florencia Fregnan Zambom et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2019)
Tetrahydroxy Stilbene Glucoside Alleviates High Glucose-Induced MPC5 Podocytes Injury Through Suppression of NLRP3 Inflammasome
Jinfeng Li et al.
AMERICAN JOURNAL OF THE MEDICAL SCIENCES (2018)
Naringin ameliorates the high glucose-induced rat mesangial cell inflammatory reaction by modulating the NLRP3 Inflammasome
Fenqin Chen et al.
BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE (2018)
Artesunate ameliorates high glucose-induced rat glomerular mesangial cell injury by suppressing the TLR4/NF-κB/NLRP3 inflammasome pathway
Zhiqiang Sun et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2018)
Weicao capsule ameliorates renal injury through increasing autophagy and NLRP3 degradation in UAN rats
Jiacai Hu et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2018)
Renal immune surveillance and dipeptidase-1 contribute to contrast-induced acute kidney injury
Arthur Lau et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
Targeting the NLRP3 inflammasome in inflammatory diseases
Matthew S. J. Mangan et al.
NATURE REVIEWS DRUG DISCOVERY (2018)
Coptidis Rhizoma inhibits NLRP3 inflammasome activation and alleviates renal damage in early obesity-related glomerulopathy
Ren Yanlin et al.
PHYTOMEDICINE (2018)
Protective effects of sarsasapogenin against early stage of diabetic nephropathy in rats
Yao-Wu Liu et al.
PHYTOTHERAPY RESEARCH (2018)
Reactive oxygen species promote tubular injury in diabetic nephropathy: The role of the mitochondrial ros-txnip-nlrp3 biological axis
Yachun Han et al.
REDOX BIOLOGY (2018)
Knockdown of TLR4 attenuates high glucose-induced podocyte injury via the NALP3/ASC/Caspase-1 signaling pathway
Yang Liu et al.
BIOMEDICINE & PHARMACOTHERAPY (2018)
Knockdown of NLRP3 alleviates high glucose or TGFB1-induced EMT in human renal tubular cells
Shan Song et al.
JOURNAL OF MOLECULAR ENDOCRINOLOGY (2018)
Purinergic 2X7 Receptor is Involved in the Podocyte Damage of Obesity-Related Glomerulopathy via Activating Nucleotide-Binding and Oligomerization Domain-Like Receptor Protein 3 Inflammasome
Xiao-Xia Hou et al.
CHINESE MEDICAL JOURNAL (2018)
Palmitate aggravates proteinuria-induced cell death and inflammation via CD36-inflammasome axis in the proximal tubular cells of obese mice
Lung-Chih Li et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2018)
NLRP3 inflammasome as a novel target for docosahexaenoic acid metabolites to abrogate glomerular injury
Guangbi Li et al.
JOURNAL OF LIPID RESEARCH (2017)
Kidney disease and obesity: epidemiology, mechanisms and treatment
Niels Olsen Saraiva Camara et al.
NATURE REVIEWS NEPHROLOGY (2017)
The metabolic syndrome and chronic kidney disease
Xin Zhang et al.
TRANSLATIONAL RESEARCH (2017)
Curcumin Ameliorates Diabetic Nephropathy by Suppressing NLRP3 Inflammasome Signaling
Miaomiao Lu et al.
BIOMED RESEARCH INTERNATIONAL (2017)
Salidroside alleviates high glucose-induced oxidative stress and extracellular matrix accumulation in rat glomerular mesangial cells by the TXNIP-NLRP3 inflammasome pathway
Shiying Wang et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2017)
Inflammasome activity is essential for one kidney/deoxycorticosterone acetate/salt-induced hypertension in mice
S. M. Krishnan et al.
BRITISH JOURNAL OF PHARMACOLOGY (2016)
Astilbin improves potassium oxonate-induced hyperuricemia and kidney injury through regulating oxidative stress and inflammation response in mice
Ming Wang et al.
BIOMEDICINE & PHARMACOTHERAPY (2016)
The cell biology of inflammasomes: Mechanisms of inflammasome activation and regulation
Deepika Sharma et al.
JOURNAL OF CELL BIOLOGY (2016)
Caspase-1, but Not Caspase-3, Promotes Diabetic Nephropathy
Khurrum Shahzad et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2016)
Cepharanthine and Piperine ameliorate diabetic nephropathy in rats: role of NF-κB and NLRP3 inflammasome
Yara A. Samra et al.
LIFE SCIENCES (2016)
High Glucose and Lipopolysaccharide Prime NLRP3 Inflammasome via ROS/TXNIP Pathway in Mesangial Cells
Hong Feng et al.
JOURNAL OF DIABETES RESEARCH (2016)
NLRP3 deletion protects against renal fibrosis and attenuates mitochondrial abnormality in mouse with 5/6 nephrectomy
Wei Gong et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2016)
Protective Action of Anandamide and Its COX-2 Metabolite against L-Homocysteine-Induced NLRP3 Inflammasome Activation and Injury in Podocytes
Guangbi Li et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2016)
The Molecular Physiology of Uric Acid Homeostasis
Asim K. Mandal et al.
ANNUAL REVIEW OF PHYSIOLOGY, VOL 77 (2015)
Nlrp3-inflammasome activation in non-myeloid-derived cells aggravates diabetic nephropathy
Khurrum Shahzad et al.
KIDNEY INTERNATIONAL (2015)
Metabolic syndrome: a sympathetic disease?
Markus Schlaich et al.
LANCET DIABETES & ENDOCRINOLOGY (2015)
IL-1β and IL-18: inflammatory markers or mediators of hypertension?
S. M. Krishnan et al.
BRITISH JOURNAL OF PHARMACOLOGY (2014)
Inhibition of Hyperhomocysteinemia-Induced Inflammasome Activation and Glomerular Sclerosis by NLRP3 Gene Deletion
Min Xia et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2014)
The emerging role of the inflammasome in kidney diseases
Anthony Chang et al.
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION (2014)
Contribution of endogenously produced reactive oxygen species to the activation of podocyte NLRP3 inflammasomes in hyperhomocysteinemia
Justine M. Abais et al.
FREE RADICAL BIOLOGY AND MEDICINE (2014)
Nod-like Receptor Protein 3 (NLRP3) Inflammasome Activation and Podocyte Injury via Thioredoxin-Interacting Protein (TXNIP) during Hyperhomocysteinemia
Justine M. Abais et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Association of Metabolic Syndrome with Decreased Glomerular Filtration Rate among 75,468 Chinese Adults: A Cross-Sectional Study
Hui Song et al.
PLOS ONE (2014)
Diabetic nephropathy and inflammation
Montserrat B. Duran-Salgado et al.
WORLD JOURNAL OF DIABETES (2014)
Association of Metabolic Syndrome With Kidney Function and Histology in Living Kidney Donors
Y. Ohashi et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2013)
NADPH Oxidase-Mediated Triggering of Inflammasome Activation in Mouse Podocytes and Glomeruli During Hyperhomocysteinemia
Justine M. Abais et al.
ANTIOXIDANTS & REDOX SIGNALING (2013)
The insulin receptor and the kidney
Lorna J. Hale et al.
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION (2013)
Mechanisms of NOD-like Receptor-Associated Inflammasome Activation
Haitao Wen et al.
IMMUNITY (2013)
ATP-P2X4 signaling mediates NLRP3 inflammasome activation: A novel pathway of diabetic nephropathy
Kehong Chen et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2013)
Inflammasomes and Their Roles in Health and Disease
Mohamed Lamkanfi et al.
ANNUAL REVIEW OF CELL AND DEVELOPMENTAL BIOLOGY, VOL 28 (2012)
Allopurinol, quercetin and rutin ameliorate renal NLRP3 inflammasome activation and lipid accumulation in fructose-fed rats
Qing-Hua Hu et al.
BIOCHEMICAL PHARMACOLOGY (2012)
Activation of Nod-Like Receptor Protein 3 Inflammasomes Turns on Podocyte Injury and Glomerular Sclerosis in Hyperhomocysteinemia
Chun Zhang et al.
HYPERTENSION (2012)
Pre-Diabetes, Metabolic Syndrome, and Cardiovascular Risk
Scott M. Grundy
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2012)
The podocyte as a target for therapies-new and old
Peter W. Mathieson
NATURE REVIEWS NEPHROLOGY (2012)
Anti-GBM Glomerulonephritis Involves IL-1 but Is Independent of NLRP3/ASC Inflammasome-Mediated Activation of Caspase-1
Julia Lichtnekert et al.
PLOS ONE (2011)
Inflammasome and IL-1β-Mediated Disorders
Hal M. Hoffman et al.
CURRENT ALLERGY AND ASTHMA REPORTS (2010)
Molecular Mechanism of NLRP3 Inflammasome Activation
Chengcheng Jin et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2010)
NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals
Peter Duewell et al.
NATURE (2010)
Thioredoxin-interacting protein links oxidative stress to inflammasome activation
Rongbin Zhou et al.
NATURE IMMUNOLOGY (2010)
Impact of treating the metabolic syndrome on chronic kidney disease
Varun Agrawal et al.
NATURE REVIEWS NEPHROLOGY (2009)
Hyperhomocysteinemia is associated with cognitive impairment in multiple sclerosis
C. Russo et al.
JOURNAL OF NEUROLOGY (2008)
Activation of the NALP3 inflammasome is triggered by low intracellular potassium concentration
V. Petrilli et al.
CELL DEATH AND DIFFERENTIATION (2007)
Obesity and obesity-initiated metabolic syndrome: Mechanistic links to chronic kidney disease
Ihab M. Wahba et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2007)
Metabolic syndrome: Connecting and reconciling cardiovascular and diabetes worlds
SM Grundy
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2006)
Hyperuricemia as a risk factor for contrast-induced nephropathy in patients with chronic kidney disease
O Toprak et al.
CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS (2006)
The metabolic syndrome and chronic kidney disease in US adults
J Chen et al.
ANNALS OF INTERNAL MEDICINE (2004)
Increasing prevalance of the metabolic syndrome among U.S adults
ES Ford et al.
DIABETES CARE (2004)
Prevalence of the metabolic syndrome among US adults - Findings from the Third National Health and Nutrition Examination Survey
ES Ford et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2002)
Share Paper
